Single Ventricle
13
3
3
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
7.7%
1 terminated out of 13 trials
88.9%
+2.4% vs benchmark
15%
2 trials in Phase 3/4
50%
4 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (13)
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)
An Integrated Prenatal and Postnatal Treatment Model for the Treatment of Newborns With Critical Congenital Heart Disease
Frailty in Children With Cardiac Disease
Cardiovascular, Pulmonary and Skeletal Muscle Evaluation Postoperative in Fontan Patients: Effects of Exercise Training
Perioperative Treprostinil in Pediatric Patients Undergoing the Fontan Operation
Transcoronary Infusion of Cardiac Progenitor Cells in Patients With Single Ventricle Physiology
Effect of Carvedilol on Exercise Performance in Fontan Patients
Diffuse Myocardial Fibrosis in Fontan Patients
Changes in Cerebral Oxygenation During Laparoscopy in Patients With Single Ventricle Anatomy
Improving Functional Capacity in Fontan Patients Through Inspiratory Muscle Training
Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients
Single Ventricle Outcome